Search Within

Paul Chapman

Formats
  1. Journal Article (206)
  2. Meeting Abstract (109)
  3. Book Section (8)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (327)
  2. Department of Medicine (327)
  3. Melanoma and Immunotherapeutics Service (327)
  4. Solid Tumor Oncology Division (327)
  5. GSK Faculty (133)
  6. Melanoma Disease Management Team (93)

More Groups

People
  1. Jedd Wolchok (107)
  2. Katherine Panageas (77)
  3. Alan Houghton (60)
  4. Michael Postow (55)
  5. Margaret Callahan (50)
  6. Alexander Shoushtari (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (2)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Clinical Cancer Research (29)
  3. Cancer Research (15)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (13)
  5. New England Journal of Medicine (11)
  6. Melanoma Research (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (60)
  3. Elsevier Inc. (22)
  4. Lippincott Williams & Wilkins (19)
  5. Wiley Blackwell (19)
  6. Oxford University Press (13)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fine specificity of NKT cells against GD3 ganglioside and identification of GM3 as an inhibitory NKT cell ligand
    Meeting Abstract

    Park, J. E.; Wu, D. Y.; Lu, S. X.; Chapman, P. B.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Stage IV melanoma and pulmonary metastases: Factors predictive of survival
    Meeting Abstract

    Neuman, H. B.; Patel, A.; Hanlon, C.; Chapman, P. B.; Wolchok, J. D.; Houghton, A. N.; Coit, D. G.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer
    Meeting Abstract

    LoRusso, P. A.; Krishnamurthi, S. S.; Rinehart, J. J.; Nabell, L. M.; Croghan, G. A.; Chapman, P. B.; Selaru, P.; Kim, S.; Ricart, A. D.; Wilner, K. D.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma
    Journal Article

    Yancovitz, M.; Yoon, J.; Mikhail, M.; Gai, W.; Shapiro, R. L.; Berman, R. S.; Pavlick, A. C.; Chapman, P. B.; Osman, I.; Polsky, D.
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma
    Journal Article

    Wolchok, J. D.; Yuan, J.; Houghton, A. N.; Gallardo, H. F.; Rasalan, T. S.; Wang, J.; Zhang, Y.; Ranganathan, R.; Chapman, P. B.; Krown, S. E.; more...
    Molecular Therapy (2007)

    Fulltext@MSK | Save
  • Adjuvant therapy of melanoma
    Journal Article

    Shah, G. D.; Chapman, P. B.
    The Cancer Journal (2007)

    Fulltext@MSK | Save
  • When you look matters: The effect of assessment schedule on progression-free survival
    Journal Article

    Panageas, K. S.; Ben-Porat, L.; Dickler, M. N.; Chapman, P. B.; Schrag, D.
    JNCI: Journal of the National Cancer Institute (2007)

    Fulltext@MSK | Save
  • Detection of melanoma cells in sentinel lymph nodes by PCR is not yet ready for prime time
    Journal Article

    Chapman, P. B.
    Pigment Cell Research (2007)

    Fulltext@MSK | Save
  • Melanoma vaccines
    Journal Article

    Chapman, P. B.
    Seminars in Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of extended-dosing temozolomide in patients with melanoma
    Meeting Abstract

    Rietschel, P.; Ejadi, S.; Wolchok, J.; Krown, S.; Gerst, S.; Jungbluth, A. A.; Busam, K.; Smith, K.; Panageas, K.; Chapman, P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save